drugset / Trial / NCT00941018
Single and Multiple Ascending Oral Dose Study of RX-10001 in Healthy Volunteers
RandomizedCrossoverQuadruple-blindTreatment
Summary
This study is being conducted to determine the safety, tolerability, pharmacodynamics and pharmacokinetics of RX-10001.
Timeline
- Start
- 2009-06
- Primary completion
- 2009-09
- Completion
- 2009-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | RESOLVIN E1 | Small molecule | 300 mg | Oral |
Indications
No indication recorded.